Eyenovia, Inc. Closes the Offering of Common Stock

Eyenovia, Inc. has closed its ongoing underwritten public offering of its common stock comprisin of 3,333,334 shares at a price common share holder of $3.60 on every share.

Eyenovia received net proceeds of $10.9 million from the offering. These net proceeds  concluded on taking off underwriting discounts and commissions and expenses on offering that were paid by Eyenovia. The company will use these proceeds along with the existing funds for funding the ongoing clinical development of its product candidates, project of initial commercialization for MicroStat, and to add into working capital along with the general corporate purposes.

Eyenovia, is basically a clinical stage ophthalmic biopharmaceutical company which is involved in developing a pipeline of microdose array print therapeutics.

in connection with the offering, William Blair & Company, L.L.C. took part as the sole book-running manager while National Securities Corporation worked as the co-manager.

Eyenovia’s pipeline is currently centered around the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.

Knight Therapeutics Announces the Results of Tender Offer for Grupo Biotoscana

Knight Therapeutics Inc. has completed the Tender offer that it has committed for over 95% ownership of Grupo Biotoscana. The pan-American specialty pharmaceutical company has posted the results of the tender offer process which was purposed for the acquisition of all Biotoscana Investments S.A. provided related outstanding Brazilian Depositary Receipts. A total of 49,778,512 of BDRs were tendered by BDR holders thereby resulting in Knight owning 98% of all outstanding GBT shares and BDRs. The settlement of the Tender Offer shall occur on August 18, 2020. On the Settlement Date, Knight will payout a total of R$517,837,423.

According to report on the date hereof 169,757 BDRs were offered in the tender at the Offer Price. Knight will pay R$11.23 for every BDR to its Holders who decided the price. Knight will pay R$8.98 one every BDR on the Settlement Date in cash while R$2.25 per BDR will be deposited in an escrow account in order to provide the benefit to BDRs Holders. The amount of R$0.91 is purposed to be at any time before November 29, 2022, and 49,608,755 BDRs were offered in the tendere for the Alternative Offer Price. Knight is subject to pay in cash R$10.40 on every BDR to BDR Holders who chose this price. While the Brazilian Depositary Receipts that are left on settlement date would be less than 5% of the total capital stock of GBT.

Knight approved the squeeze out of the remaining BDRs that the details it provided in the Notice. Knight will delist the GBT in Brazil and Luxembourg after Squeeze-Out.

BDR Holders have three days to elect the get Offer Price’s final auction value or it would be able to choose the Alternative Offer Price subject to the adjustment of the Selic Rate. According to the terms Knight keeps the right to buy BDRs at the Offer Price Alternative to BDR Holders if they, subject to Deadline Squeeze-Out, don’t provide the necessary documents and information.

Anomali partners will get help from OneWorld InfoTech to enhance Deployment and endorsement of Cyber Threat Intelligence in Bangladesh

For giving the ability to deploy and endorse Anomali threat intelligence management solutions in Bangladesh Anomali, engaged in providing intelligence-driven cybersecurity solutions, has agreed for a collaboration with OneWorld InfoTech, which provides technology and distribute IT security solutions in Bangladesh.

Anomali VP, Asia Pacific Geoff Noble said constant attacks on the organizations can’t be detected and responded without a high level of visibility over the cyberthreats. He added, “We are excited to partner with the top cybersecurity provider in Bangladesh, OneWorld InfoTech, to help customers there gain access to integrated cyber threat intelligence (CTI) solutions that will help them to improve security and reduce risk.”

While OneWorld InfoTech Global Director of Technology and Services Maruf Ahmed gave his views, “Anomali brings a unique approach to connect external data with internal knowledge to operationalize a unified intelligence picture for organizations to reduce risk across their environments. By expanding our IT security portfolio offering with Anomali, we expect to assist organizations in Bangladesh private and public sectors in building effective cyber threat intelligence program and threat sharing communities to bolster defenses exponentially.”

According to the details provided, joint customers of both businesses receive the most advanced, broad, and easy-to-use CTI solutions. The Anomali delivers Lens, a first-of-its-kind technology enables anyone to automatically know if the organizations are being attacked. Anomali Match integrates the tools related to CTI, MISP data, OSINT, SIEM logs, vulnerability assessment, and provides other big data sources to match the billions of indicators of compromise (IOCs) and menaces against any thing that is present in customers’ networks. While Anomali ThreatStream is threat intelligence tool (TIP) compensate data from the broader range of feeds to create actionable threat intelligence.

Sherwin-Williams Announces Q2 2020 Sales Guidance

Sherwin-Williams has announced the Q2 2020 sales guidance. The company has said that it had increased its net sales guidance for Q2 2020. The company expects that the consolidated net sales of the company will decrease by a significant margin than the previous quarter of 2019. The company has issued the prior guidance, issued in April 2020 for Q2 2020 consolidated net sales decreased to mid-teen percentage as compared to the previous quarter of 2019.

The company has said that the net sales in The Americas Group are expected to decrease in the Q2 2020 as compared to the previous quarter. The company is scheduled to release the Q2 2020 financial results on July 28, 2020.

Chief Executive Officer and Chairman of the company, John Morikis said, “Our employees have performed admirably during this challenging time to meet our customers’ needs.”

“We are raising our second quarter sales guidance given our ability to capture and serve greater than expected demand in our North American architectural businesses,” John Morikis further added in the statement.

“We are encouraged by the sequential improvement in all three of our business segments during the second quarter. In The Americas Group, we rapidly adapted to the pandemic by implementing curbside pickup in our stores, utilizing our fleet of over 3,000 delivery vehicles, and leveraging our e-commerce platform. We have gradually and safely reopened nearly all of our sales floors over the last month,” John Morikis said.”

“DIY growth in our stores remains strong, while our residential repaint and new residential segments have improved at a faster rate than our property management, new commercial and protective and marine segments. In the Consumer Brands Group, the unprecedented demand from most of our retail partners has remained robust, driven by consumers who are nesting during the pandemic and focused on DIY projects. In the Performance Coatings Group, demand has been variable by end market and geography,” John Morikus concluded.

Calvert Research And Management Launches Calvert ESG Leaders Strategies

Calvert Research and management has announced that the company has launched Calvert ESG Leaders Strategies to articulate the separate account strategies for individual and institutional investors. The Calvert ESG Leaders Strategies are co-managed by Chris Madden and Jade Huang, who are serving as the Portfolio Manager and Vice Presidents at Calvert Research and Management Group.

The Calvert ESG Leaders Strategies seek to make investments specifically at those companies that are qualified according to the parameters of emerging leaders or leaders in ESG factors. The overall investment process of the company consists of basically three major components as corporate engagement, stock selection and portfolio optimization.

Chief Executive Officer and President of Calvert Research and Management, John Streur said, “Calvert’s proprietary, industry-leading research system enables us to identify companies that are leading their peers in managing financially material ESG risks, and which may be poised to take advantage of business opportunities based on their knowledge of and commitment to meaningful ESG practices.”

“Financial materiality is a critical component of ESG analysis. We believe understanding the connection between sustainability factors and business success sets these companies apart and positions them to maneuver efficiently and effectively in an evolving world,” company’s President and CEO John Streur further added in his statement.

Ms. Huang said, “In developing the strategies, we conducted a quantitative review of ESG leaders’ past performance. The results indicate that companies that achieved top ESG scores in financially material factors have historically produced stronger financial performance than those with weaker ESG scores.”

“Additionally, we found that by optimizing the portfolios, we could position the strategies to achieve positive environmental and societal impact by increasing exposure to companies with healthier environmental footprints and better gender diversity,” Ms. Huang further added in her statement.

Escalade Sports Donates 1,000 N95 In Evansville To Help The Local Community To Fight Covid-19 Pandemic

Escalade Sports has announced that the company has donated the 1,000 N95 face masks in the city of Evansville to help the local community to fight the ongoing Covid-19 pandemic.

The company has further added that it has collaborated with the Emergency Management Director of the city to distribute the N95 face masks to the needy and deserving people of the city. The company has said that it will distribute the N95 face masks to the needy, poor and deserving people of the city.

Escalade Sports is a global leader and manufacturer of sports goods and recreational equipment. The leading sport brands of the company include, SUK and Cajun Bowfishing, Bear X, Bear Archery, Ping-Pong Table Tennis, Victory Tailgate, Triumph Sports, Onix, DURA, Zume Games, Goalsetter, Goalrilla, STIGA, Goaliath, Silverback, STEP, Lifeline, Vuly, Woodplay, Cue&Cast, Unicorn Darting, Atomic, among others.

All the company’s sporting line is available at the independent retailers and sporting goods dealers across the United States.

President and Chief Executive Officer of Escalade Sports, Scott Sincerbeaux said, “As an organization, giving back to the communities in which we operate is one of our key core values and we are committed to taking a proactive role to help support the city of Evansville and its frontline workers.”

“This pandemic is unprecedented, but we know that the path forward requires everyone working together and helping our local communities is part of who we are at Escalade Sports,” Scott Sincerbeaux further added.

“We are grateful for the generous support of Escalade Sports. “As a long time, reliable corporate citizen, I am pleased that Escalade continues to recognize the role it can play in assisting the city as we continue to deal with the pandemic,” said Evansville Mayor Lloyd Winnecke.

Greif Reports Q2 2020 Financial Results

Greif has announced the company second quarter 2020 financial results. According to the details, the company generated the net income of $11.4 million per diluted class A share as compared to the net income of $13.6 million from the previous quarter. The net cash of the company provided by the operating activities increased by $37.7 million to $99.8 million in the second quarter 2020 financial results.

The adjusted free cash flow of the company increased from $32.9 million to $79.0 million. The total debt of the company decreased by $260.2 million to $2,682.3 million. The net sales of the company decreased by $29 million to $602.6 million. The operating profit of the company increased by $23.5 million to $70.5 million.

Chief Executive Officer and President of Greif, Pete Watson said, “At Greif, we safely package and protect essential goods and materials that serve the greater needs of communities around the world. That is our purpose as a Company and a serious responsibility in which we take pride. While we are operating in a highly unprecedented time, we continue to draw strength from our 16,000 global colleagues, and I commend them for their efforts this past quarter.”

“We are responding to COVID-19 from a position of strength, taking proactive steps to prioritize the safety and well-being of our colleagues, customers and suppliers while adapting to new methods to further serve customer needs. We are also advancing our strategic priorities, and during the quarter took steps to enhance our U.S. IBC reconditioning capability and published our 11th annual sustainability report,” Pete Watson added.

“From a financial perspective, the business generated solid second quarter results. Adjusted EBITDA rose by 12 percent to $181.3 million, while Adjusted Free Cash Flow increased by more than 71 percent to $79.0 million,” Pete Watson concluded.

EpicentRX Appoints New Chief Executive Officer

EpicentRX has announced that it has appointed a renowned oncologist, physician and scientists Tony Reid, M.D, Ph.D. as the company’s new Chief Executive Officer (CEO) with immediate effect. The company’s newly appointed Chief Executive Officer Dr. Tony Raid is also the co-founder of the company and has got nearly 2 decades of experience in the domain of drug development. His other areas of expertise, including the licensing and acquisition, translational medicine, new product development and clinical strategy.

Furthermore, Dr. Tony Reid is also serving as the oncologist at the Rebecca and John Moores Cancer Institute at UCSD, where he is working on the domain of gastrointestinal malignancies.

Chief Financial Officer of EpicentRX, Franck Brinkhaus said “We look forward to an exciting period of growth for our research and clinical efforts under Tony’s leadership.”

Chairman of EpicentRX Board of Directors, Arnold Oronsky said, “Tony Reid has more than 20 years of experience in the pharmaceutical industry and has been an invaluable member of our senior management team.”

“Since joining EpicentRx, Tony has played a key role in the ongoing development of RRx-001, now in Phase 3, and is currently spearheading the company’s efforts with its oncolytic adenoviral and anti-COVID platforms. I am confident that he is exactly the right person to lead EpicentRx,” Arnold Oronsky further added.

Sharing his thoughts, Dr. Tony Reid said, “As an oncologist, I’ve seen firsthand the limitations of our present-day approach to the treatment of cancer. With EpicentRx, we have a profound opportunity to change the dynamic of oncology treatment so that patients may potentially live longer with fewer side effects.”

“I feel privileged to be given the opportunity to take on the role of CEO of EpicentRx during this critical time in the company’s history. Over the past several months, the Executive Team and I have been working closely with the Board to position the Company for future growth. I am hopeful that we will be able to execute on our plan to drive long-term value for our investors and for patients, which is ultimately why I joined EpicentRx and why we do what we do,” Dr. Tony Reid continued.

Investment Management Corporation of Ontario Commits 250 Million USD To Apollo Global Management In Accord Fund III Series B

Investment Management Corporation of Ontario (IMCO) has announced that the company has committed 250 Million USD to Apollo Global Management In New Accord Fund III Series B. The proposed funding would be used by the company to enter the market during periods of illiquidity and dislocation. The Global Credit Team of the Investment Management Corporation (IMCO) has closed its commitment on April 23, 2020, making its one of the world’s largest investment managers.

Managing Director at Global Credit, Jennifer Hatviksen said, “Our participation in this fund demonstrates how nimble our team can be in seeking valuable opportunities for our clients.”

“This is an example of IMCO adapting to market conditions and exploiting our liquidity very quickly so that clients have access to dislocated opportunities as they arise,” Jennifer Hatviksen further added.

Senior Managing Director at Private Equities and Credit, Christian Hensley said, “As our program scales, we are initially relying on experienced strategic partners.”

“The investment in this Fund is an example of the types of opportunities we’re pursuing — investments with sponsors that we believe have deep expertise, delivering diversifying and differentiating exposures, who are transparent, opportunistic, and value-oriented,” Christian Hensley further added.

The Investment Management Corporation of Ontario manages more than 70.3 Billion USD of assets on the behalf of its clients. It is the mission of the company to provide broader investment management services to its clients by adopting different strategies.

The Investment Management Corporation of Ontario (IMCO) has further added that it has recently launched its Global Credit Program to contribute additional diversification benefits and to provide higher risk-adjusted returns than traditional fixed income.

The fundamental approach and expertise of Apollo Global Management allows for selective deployment during market volatility and stability that is totally in line with recommendations of the Investment Management Corporation of Ontario (IMCO).

Micah Litow Assumes Dual Responsibilities In Kalderos

Kalderos, the creator of drug discount management solution, has announced on Wednesday April 29, 2020 that the company has promoted the Company’s COO Micah Litow as the President of the company and he will now assume the responsibilities of both the President and Chief Operating Officer.

According to the details released by the PR Newswire News Agency, the company’s new President and COO will be responsible for leading additional business activities of the company, sales, marketing, product management, finance and as well as commercial operations.

Additionally, the Micah Litow would also oversee the functions of the new customer success teams and consolidated data management to create and unified a central team.

The newly appointed President of the company has joined the company back in 2018. He has experience in leading, launching and managing more than a dozen healthcare products, including consumables.

Sharing his thoughts over the new appointment, Micah Litow said, “We are an ambitious group of innovators with diverse backgrounds and skillsets and with a shared commitment to Kalderos’ mission and vision.”

“I am honored by this appointment and humbled by what we’ve collectively accomplished thus far. It’s a privilege to work alongside passionate individuals as we bring an infrastructure rooted in transparency to fruition,” added Micah Litow.

Co-founder and Chief Executive Officer of Kalderos, Jeremy Docken said, “Micah’s contributions have been instrumental in what we’ve achieved to this point and will continue to be for all that we have planned in the future. He’s a true leader and I am confident that he will thrive in his new role as we push toward our future.”

Kalderos Board Member and Director at Mercato Partners, Joe Kaiser said, “Kalderos’ team exudes the willpower needed to tackle complex healthcare issues — and Micah exemplifies this grit. “Kalderos’ mission and team will undoubtedly benefit from his recent appointment.”